Chinh E Chu

Mr Chinh E Chu

Overview

Mr Chu has led Blackstone’s investments in Stiefel Laboratories, ReAble Therapeutics’ acquisition of DJ Orthopedics, Biomet, Catalent Pharma Solutions, Alliant, ReAble Therapeutics, Celanese, Nalco, SunGard Data Systems, Nycomed, and LIFFE. He has also been involved in Blackstone’s investments in FGIC, Graham Packaging, Sirius Satellite Radio, StorageApps, Haynes International, Prime Succession/Rose Hills, Interstate Hotels, HFS and Alco Holdings. Before joining Blackstone in 1990, Mr Chu worked at Salomon Brothers in the Mergers & Acquisitions Department.
He currently serves as a Director of Alliant, Healthmarkets, DJO Inc, Catalent Pharma Solutions, SunGard, Graham Packaging, and FGIC.
Mr Chu received a BS in Finance from the University of Buffalo, where he graduated summa cum laude.

Career

Private equity firm
Position:
Senior Managing Director - Corporate Private Equity (New York) (current)

Add education